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Pneumocystis jirovecii pneumonia (PCP) typically presents as an interstitial and alveolar process with ground glass opacities on
chest computed tomography (CT).+e absence of ground glass opacities on chest CT is thought to have a high negative predictive
value for PCP in individuals with AIDS. Here, we report a case of PCP in a man with AIDS who presented to our hospital with
subacute shortness of breath and a nonproductive cough. While his chest CT revealed di5use nodular rather than ground glass
opacities, bronchoscopy with bronchoalveolar lavage and transbronchial biopsies con6rmed the diagnosis of PCP and did not
identify additional pathogens. PCP was not the expected diagnosis based on chest CT, but it otherwise 6t well with the patient’s
clinical and laboratory presentation. In the era of combination antiretroviral therapy, routine prophylaxis for PCP, and increased
use of computed tomography, it may be that PCP will increasingly present with nonclassical chest radiographic patterns.
Clinicians should be aware of this presentation when selecting diagnostic and management strategies.
1. Introduction
Pneumocystis jirovecii pneumonia (PCP) is a potentially life-
threatening infection that most often occurs in immuno-
compromised hosts. PCP was the most frequent complication
of HIV/AIDS in the early phases of the epidemic, and while
its incidence has declined substantially in the current era of
combination antiretroviral therapy, it remains one of themost
common HIV-associated opportunistic infections.
Generally, the diagnosis of PCP is suggested by a subacute
illness featuring fever, nonproductive cough, malaise, and
progressive shortness of breath [1]. Dyspnea and hypoxemia
can be profound. Lung auscultation and chest roentgenogram
can both be normal, but computed tomography (CT) of the
chest typically demonstrates “ground glass opacities” [2, 3].
+is is likely due to the accumulation of cellular debris,
6brin, and organisms within the alveolar spaces [2], as well
as interstitial inBammation. Other radiographic patterns of
PCP include a predilection for upper lobes (particularly in
patients who use aerosolized pentamidine for prophylaxis),
a preference for central rather than peripheral zones, and
a tendency to form cysts [1, 4, 5]. Several serum tests can be
used to help determine the likelihood of PCP, but mi-
croscopic visualization of induced sputum or bronchoalveolar
lavage Buid specimens remains the gold standard for di-
agnosis [6].
A previous publication from our institution suggested
that the presence of ground glass on high-resolution chest
CT (HRCT) is 100% sensitive for PCP in patients with
AIDS [7]. In other words, the absence of ground glass
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opacities on HRCT ruled out the diagnosis of PCP in such
patients. Based on these data, our standard clinical practice has
been to recommend against additional diagnostic testing and
empiric PCP therapy for HIV-infected patients when their
chest HRCT does not contain ground glass opacities, even in
the setting of a clinical syndrome suggestive of PCP [8].
Here, we report a case of PCP with an unusual radio-
graphic appearance consisting of nodular opacities without
ground glass on chest CT. While the clinical syndrome was
convincing for PCP, the radiographic presentation made
PCP seem unlikely and led to an interruption of PCP
therapy.
2. Case Presentation
A 57-year-old man was admitted to our hospital with a four-
week history of nonproductive cough and dyspnea. His past
medical history was notable for type II diabetes mellitus,
chronic kidney disease with a baseline creatinine of
1.3mg/dL, and untreated HIV/AIDS, which had been di-
agnosed 20 years previously. Prior opportunistic infections
included oral candidiasis and cryptococcal meningitis. He
was allergic to sulfonamides and had been prescribed
dapsone for PCP prophylaxis, but he was not taking it re-
liably. His most recent known CD4 count and HIV viral
load, 11 months prior to admission, were 15 cells/uL and
148,582 copies/mL, respectively.
Four days prior to presenting to our emergency de-
partment, the patient was admitted to another hospital with the
same symptoms of nonproductive cough and shortness of
breath. Chest radiograph at that time showed di5use micro-
nodules, greater in the right lung (Figure 1). +ere, he was
empirically treated for both community-acquired pneumonia
and PCP with ceftriaxone, azithromycin, clindamycin, pri-
maquine, and steroids. He was also given Buconazole for
thrush. Unfortunately, he left that facility against medical
advice after 48 hours. He took no further treatment before
coming to our hospital two days later.
When he subsequently came to our emergency de-
partment complaining of ongoing shortness of breath and
cough, temperature was 35.9 degree Celsius, heart rate 119
beats per minute, blood pressure 107/71mmHg, respiratory
rate 18 breaths per minute, and oxygen saturation 96%
while breathing ambient air. He was ill-appearing with
conjunctival pallor and oral thrush. +e remainder of his
physical examination was normal, including chest aus-
cultation, which revealed good air movement without
wheezing, rales, or rhonchi. Laboratory analysis was
notable for white blood cell count of 6,200 cells/uL with
63% neutrophils, 19% lymphocytes, 13% monocytes, and
3% eosinophils, elevated lactate dehydrogenase of 385 u/L,
and positive beta-D-glucan of 389 pg/mL (Table 1). Chest
roentgenogram revealed di5use micronodules with con-
Buent areas of nodular opacities (Figure 2). On the basis of
these 6ndings, the patient was admitted to our medical
service and treated empirically for community-acquired
pneumonia with ceftriaxone and doxycycline, for thrush
with Buconazole, and for PCP with clindamycin and
primaquine.
On hospital day 2, the patient developed worsening
shortness of breath with hypoxemia requiring supple-
mental oxygen. A noncontrast, volumetric chest CT scan
(Figure 3) revealed di5use micronodules with central
cavitation and bronchial wall thickening, most suspicious
Figure 1: Chest roentgenogram at referring hospital. AP chest
radiograph at outside hospital performed 4 days prior. Di5use
micronodules greater in the right lung are seen. Hint of small
cavities is noted (blue arrows).














WBC (k/uL) 7.0 6.2 3.9–11.7
Neutrophils (%) — 63 44–68
Lymphocytes (%) — 19 25–44
Monocytes (%) — 13 0–7
Eosinophils (%) — 3 0–4
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Lactate (mmol/L) 4.7 1.7 0.5–2.2
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(immunodi5usion) — Negative Negative
CD4+ T-cells
(cells/uL) — 15 420–1250
HIV viral load
(copies/mL) — 178,887 0
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for mycobacterial or fungal infection. Notably, there were
no ground glass opacities. Based on this CT and the lack of
ground glass opacities, the treating team discontinued PCP
therapy, initiated tuberculosis treatment, and consulted the
pulmonary service for assistance and consideration of
bronchoscopy. +e patient underwent bronchoscopy with
bronchoalveolar lavage (BAL) and transbronchial biopsy
the following day. Pathologic analysis of the transbronchial
biopsy specimen demonstrated foamy exudates on he-
matoxylin and eosin- (H&E-) stained sections, and silver
stain revealed Pneumocystis jirovecii-type fungal organisms
con6rming the diagnosis to be PCP [9] (Figure 4). No
concurrent infections were found on cultures or pathologic
samples (Table 2). +e patient was treated with three
weeks of clindamycin, primaquine, and prednisone. He was
discharged home on hospital day 10 without requiring
supplemental oxygen and did well thereafter, with a reso-
lution of radiographic abnormalities on imaging obtained
four months later (Figure 5).
3. Discussion
Although the incidence of PCP has decreased since the
advent of combination antiretroviral therapy in the 1990s, it
remains among the most common pulmonary opportunistic
infections in patients with AIDS. PCP should be suspected in
the clinical setting of subacute dyspnea, nonproductive
cough, and fever. While microscopic visualization of
bronchoalveolar lavage Buid is the gold standard for di-
agnosing PCP, chest CT is increasingly being used to make
clinical decisions about empiric treatment, and whether to
pursue bronchoscopy.
Figure 2: Chest roentgenogram on admission to our hospital. AP chest radiograph at presentation. Again seen are di5use micronodules
with conBuent areas in the right upper and lower lungs. Hint of small cavities is again noted (blue arrows).
Figure 3: Selected images of computed tomography (CT) scan of the chest on admission to our hospital. Axial images in lung window
con6rm di5use micronodules with central cavitation of varying sizes (blue arrows).
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+e radiographic appearance of PCP can vary from
person to person. +e “classic” presentation on plain 6lm is
of bilateral, symmetric opacities in an interstitial or alveolar
pattern [3, 10]. Chest CT in patients with AIDS who develop
PCP most often shows ground glass opacities [2, 4, 11, 12].
However, PCP has also been described to present in-
frequently with additional 6ndings including cystic lung
disease, pneumothoraces, and nodules, among other pat-
terns [2, 3, 13].
It is not entirely surprising that PCP can have a variety of
radiographic presentations. As a pathogen that primarily
causes disease in the immunosuppressed, PCP often occurs in
lungs that have been damaged by prior infections, distorting
their architecture. Moreover, it is not uncommon for PCP to
co-occur with another infection in an immunocompromised
host. In such a circumstance, the radiographic signature of
PCP may be subsumed by the coinfecting pathogen.
At our institution where we have extensive experience
caring for patients with HIV/AIDS, a chest CT without
ground glass is generally thought to “rule out” PCP in
patients with AIDS. +is is based on a 1997 study of 51
patients with AIDS and a clinical syndrome consistent with
PCP but normal chest roentgenogram who underwent
HRCTof the chest [7]. In this cohort, the absence of ground
glass opacities on chest CT had a perfect negative predictive
value for Pneumocystis pneumonia (i.e., the presence of
ground glass was 100% sensitive for PCP). Knowing these
data and subsequent clinical experience, the team treating
the described patient was surprised to learn that the patient
had PCP, and PCP alone—as the absence of ground glass
(a) (b)
Figure 4: Transbronchial biopsy pathologic results. Pathologic evidence for PCP infection from the patient’s transbronchial biopsy
specimen. (a) Hematoxylin and eosin- (H&E-) stained section demonstrates classic intra-alveolar eosinophilic foamy exudates. (b) Gomori
methenamine silver (GMS) special stain demonstrates nonbudding cysts with thin walls and intracystic capsular dots, consistent with
Pneumocystis jirovecii-type fungal organisms.
Table 2: Microbiology studies.
Test name Hospital day collected Result
Blood culture x2 0 Negative
Nasopharynx inBuenza RNA 0 Negative
Blood for acid-fast bacilli 1 Negative at 42 days
Induced sputum for acid-fast bacilli 2 Negative at 56 days
Induced sputum for acid-fast bacilli 3 Negative at 56 days
Induced sputum for MTb PCR 3 Negative
Induced sputum for bacterial culture 2 Few oronasal Bora
Induced sputum for fungal culture 2 Candida albicans∗∗
BAL Buid for PCP examination 4 Many clumps of trophozoites and cysts. No viralinclusions seen. No fungi seen.
BAL Buid for fungal culture 4 Candida albicans∗∗
BAL Buid for acid-fast bacilli 4 Negative at 56 days
BAL Buid for bacterial culture 4 No organisms seen
Serum cryptococcal antigen 1 Negative
Coccidioides antibody (complement 6xation) 1 <1 : 2, Negative
Coccidioides antibody (immunodi5usion) 1 Negative
Transbronchial biopsy for acid-fast bacilli culture 4 Negative at 28 days
Transbronchial biopsy for bacterial culture 4 Negative at 56 days∗∗Patient had thrush, and this was felt to be an upper airway contaminant.
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opacities on chest CT was highly unusual. Indeed, the
treating clinicians decided to discontinue PCP-directed
therapy on the basis of the CT 6ndings.
While highly atypical, the radiographic appearance of
the described patient’s PCP is not entirely without pre-
cedent. Some of the previously mentioned publications do
describe rare instances of PCP presenting as nodules [2–4, 10].
Still, such described presentations were the exception
rather than the rule, and over the past 20 years, all cases of
PCP that we have seen at our institution have consistently
manifested as ground glass opacities on chest CT (when
obtained).
It is likely that we, and others, will encounter more cases
of PCP with “atypical” radiographic presentations. +e in-
creased access to CT scanners means more patients are
undergoing chest CTfor indications that previously may not
have led to such imaging. Our patient, for example, with
subacute cough, dyspnea, fevers, and malaise had a clinical
history consistent with PCP, and his chest roentgenogram
with regions of conBuent nodular opacities could have been
interpreted as typical of PCP. Based on the inclusion criteria
for the aforementioned 1997 study [7] from our institution,
our patient would have proceeded directly to sputum in-
duction or bronchoscopy on the basis of his clinical history
and chest roentgenogram, without 6rst having undergone
chest CT. If that course had been taken, he would have been
discovered to have PCP in the setting of a compatible clinical
history and imaging (plain 6lm) and his presentation would
have been considered entirely typical. We would not have
appreciated the exclusively nodular aspect of his disease.
Beyond the increased availability of cross-sectional
imaging with chest CT, increased access to combination
antiretroviral therapy and PCP prophylaxis may also alter
the radiographic appearance of PCP [3]. Even in patients
with inconsistent treatment adherence, the degree of im-
munosuppression, extent of opportunistic infection, and
radiographic presentation of PCP may not be directly
comparable to those with HIV who are treatment-naive.
In the case of the patient we describe, his two days of
therapy with clindamycin and primaquine at the referring
hospital could theoretically have altered his chest CT 6nding
and explained the lack of ground glass opacities. However,
this seems highly unlikely because (1) his plain 6lms on
admission to each institution were similar and (2) he
worsened clinically after receiving the initial PCP-directed
therapy. +is worsening, which is often seen with PCP,
suggests a robust alveolar and interstitial inBammatory
response, which we would expect to cause more, not fewer,
ground glass opacities on chest CT.
In summary, we describe a case of PCP in a patient with
AIDS, with classic presenting symptoms but an unusual
radiographic pattern on chest CT featuring nodular opaci-
ties and no ground glass. +e lack of ground glass opacities
resulted in brief PCP treatment interruption. CT scan
6ndings alone should not be used to discontinue PCP-
speci6c treatment, particularly in patients with a clinical
syndrome that is otherwise consistent with PCP.
Conflicts of Interest
+e authors declare that there are no conBicts of interest
regarding the publication of this paper.
Authors’ Contributions
Brian L. Block and Tejas Mehta contributed equally to this
work.
References
[1] C. F. +omas Jr. and A. H. Limper, “Pneumocystis pneu-
monia,” New England Journal of Medicine, vol. 350, no. 24,
pp. 2487–2498, 2004.
[2] J. P. Kanne, D. R. Yandow, and C. A. Meyer, “Pneumocystis
jirovecii pneumonia: high-resolution CT 6ndings in patients
with and without HIV infection,” American Journal of
Roentgenology, vol. 198, no. 6, pp. W555–W561, 2012.
[3] J. E. Kuhlman, “Pneumocystis infections: the radiologist’s
perspective,” Radiology, vol. 198, no. 3, pp. 623–635, 1996.
[4] P. M. Boiselle, C. A. Crans Jr., and M. A. Kaplan, “+e
changing face of Pneumocystis carinii pneumonia in AIDS
(a)
(b)
Figure 5: Chest roentgenogram four months after hospitalization.
(a) PA and (b) lateral chest radiographs post treatment four months
later demonstrated marked improvements.
Case Reports in Infectious Diseases 5
patients,” American Journal of Roentgenology, vol. 172, no. 5,
pp. 1301–1309, 1999.
[5] J. E. Kuhlman, M. Kavuru, E. K. Fishman, and S. S. Siegelman,
“Pneumocystis carinii pneumonia: spectrum of parenchymal
CT 6ndings,” Radiology, vol. 175, no. 3, pp. 711–714, 1990.
[6] J. Kovacs, K. Crothers, H. Furrer et al., “Guidelines for the
prevention and treatment of opportunistic infections in HIV-
infected adults and adolescents,” 2017, https://aidsinfo.nih.
gov/content6les/lvguidelines/glchunk/glchunk_321.pdf.
[7] J. F. Gruden, L. Huang, J. Turner et al., “High-resolution CT
in the evaluation of clinically suspected Pneumocystis carinii
pneumonia in AIDS patients with normal, equivocal, or
nonspeci6c radiographic 6ndings,” American Journal of
Roentgenology, vol. 169, no. 4, pp. 967–975, 1997.
[8] L. Huang, A. Cattamanchi, J. L. Davis et al., “HIV-associated
Pneumocystis pneumonia,” Proceedings of the American
4oracic Society, vol. 8, no. 3, pp. 294–300, 2011.
[9] P. H. Hartel, K. Shilo, M. Klassen-Fischer et al., “Granulo-
matous reaction to Pneumocystis jirovecii: clinicopathologic
review of 20 cases,” American Journal of Surgical Pathology,
vol. 34, no. 5, pp. 730–734, 2010.
[10] L. J. DeLorenzo, C. T. Huang, G. P. Maguire, and D. J. Stone,
“Roentgenographic patterns of Pneumocystis carinii pneu-
monia in 104 patients with AIDS,” Chest, vol. 91, no. 3,
pp. 323–327, 1987.
[11] C. J. Bergin, R. L. Wirth, G. J. Berry, and R. A. Castellino,
“Pneumocystis carinii pneumonia: CT and HRCT observa-
tions,” Journal of Computer Assisted Tomography, vol. 14,
no. 5, pp. 756–759, 1990.
[12] T. E. Hartman, S. L. Primack, N. L. Muller, and C. A. Staples,
“Diagnosis of thoracic complications in AIDS: accuracy of
CT,” American Journal of Roentgenology, vol. 162, no. 3,
pp. 547–553, 1994.
[13] G. P. Cornalba, P. Mariani, E. Colombo, R. Bianco, and
S. Vona, “Atypical radiological images in Pneumocystis carinii
infection in HIV-positive patients,” La Radiologia Medica,
vol. 87, no. 6, pp. 763–767, 1994.
6 Case Reports in Infectious Diseases
